Thrombolysis before venoarterial ECMO for high-risk pulmonary embolism: a retrospective cohort study.
David LevyOuriel SauraMaria Teresa PassarelliManuela LucenteforteGuillaume LebretonAdrien BougleAntoine MonselSofia OrtunoYoël BenithaNadjib HammoudiBenjamin AssoulineMatthieu PetitMelchior GautierLucie Le FevreMarc Pineton de ChambrunCharles JuvinJuliette ChommelouxCharles-Edouard LuytGuillaume HékimianPascal LeprinceAlain CombesMatthieu SchmidtPublished in: Intensive care medicine (2024)
Ninety-day survival and bleeding events rates did not differ in patients treated with VA-ECMO after systemic thrombolysis compared to those who were not. Recent systemic thrombolysis, as a single parameter, should not be considered as a contraindication for VA-ECMO in high-risk PE.